U.S. Cancer Death Rates Decline; How Can We Continue This Progress?
The new year began with the good news that death rates from cancer are continuing their steady decline. A...
The new year began with the good news that death rates from cancer are continuing their steady decline. A...
From June 23-26, researchers from around the world will gather in Boston for the Third AACR International Meeting on...
Highlights from Cancer Today's summer 2024 issue, including treatment-induced heart conditions, profile of Brian Jones, and more.
Cigarette smoking is the leading cause of death from lung cancer in the United States. That’s why November, Lung...
What comes to mind when you think of a fungus? A mushroom? A case of athlete’s foot or ringworm? ...
The numbers are in, and AACR Annual Meeting 2023 was a resounding success. From April 14-19, more than 20,000...
As the COVID-19 pandemic swept the globe this spring, the American Association for Cancer Research (AACR) launched a major...
Every cell in the human body contains about 300 million base pairs of double-stranded DNA that contribute to a...
As we unpack our cardigans in anticipation of cooler weather here on the East Coast, we are taking a...
Each December, an impressive cohort of breast cancer researchers gathers for the San Antonio Breast Cancer Symposium (SABCS), one...
As we welcome spring, enjoy the latest round of editors’ picks selected by the editors of AACR’s 10 journals....
In the final quarter of 2023, the FDA issued 17 approvals specifically for the treatment of tumors.
A recap of the plenary sessions, cutting-edge science, clinical trials, and more covered by the AACR blog.
April symbolizes a progressive time for cancer researchers around the world. From April 1-5, over 20,000 cancer scientists will...
Editor’s note: This post was written by Nicholas Warren, PhD, science policy program administrator in the AACR’s Office of...
Yesterday, the American Association for Cancer Research (AACR) joined the American Cancer Society (ACS), the American Society of Clinical...
Although not as common as breast, prostate, or lung cancer, kidney cancer is one of the most frequently diagnosed...
Later today, more than 200 scientists working diligently to advance the field of epigenetics research will convene in Atlanta...
News of a cancer diagnosis will shake even the most solid foundation. But young adults, who arguably seem more...
As the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved got underway...
Cody Wolf was one of 19 young scientists who visited Washington for AACR's Early-career Hill Day.
The word myeloma stems from the Greek word “myelos,” for marrow. Indeed, this type of blood cancer begins in the plasma cells, a type...
As part of a growing public affairs program, the American Association for Cancer Research is excited to once again...
Clinical trials were a major focus of the AACR Virtual Annual Meeting I, spanning nine plenary sessions over the two-day...
Cancer is often described as a disease of old age. However, certain cancers have become increasingly prevalent among younger populations...
Early-career investigators play an important role in advancing cancer research, helping spur new discoveries and the translation of these...
Dan Theodorescu and Lars Dyrskjøt preview the AACR's upcoming conference on bladder cancer.
When the AACR Annual Meeting 2015 begins April 18 in Philadelphia, more than 18,500 attendees will flow seamlessly through...
Now that a plethora of clinical trials have established positive responses from immunotherapies—immune checkpoint inhibitors, in particular—in patients with...
Multiple myeloma is a cancer of antibody-producing cells—called plasma cells—that accounts for approximately 1.8 percent of new cancer cases...